Cambio interim report Q1 2026

Cambio continued to execute on its strategy to enable tomorrow’s health and social care, today. During the first quarter, revenue increased by 3% year-on-year to 331 MSEK. Adjusted EBITDA amounted to 29 MSEK, reflecting continued investments in delivery capacity, product development and customer commitments as we move into the next phase of several large-scale customer deliveries.

Financial highlights for the 1st quarter of 2026:

• Revenue amounted to 331.3 (320.6) MSEK in the first quarter, representing growth of 3.3%
• Adjusted EBITDA amounted to 29.2 (41.2) MSEK
• Income before tax amounted to -55.5 (-46.1) MSEK
• Net income per share amount to -0.35 SEK (-0.25)

Please see our quarterly report for more insights.

For further information, please contact: 

Rami Avidan
CEO
+46 070 793 483 
rami.avidan@cambio.se

Johannes Fabó
CFO
+46 730 599 368
johannes.fabo@cambio.se

Sanolium AB, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia and a growing player in the European market, with more than 170,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.